| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A T2517C polymorphism in the GSTM4 gene is associated with risk of developing lung cancer
|
Liloglou, Triantafillos
|
|
2002
|
37 |
2 |
p. 143-146
4 p.
|
artikel
|
| 2 |
Concurrent chemoradiation therapy with cisplatin and paclitaxel for locally advanced non-small cell lung cancer: long-term follow-up of a phase I trial
|
Robert, Francisco
|
|
2002
|
37 |
2 |
p. 189-199
11 p.
|
artikel
|
| 3 |
Contents
|
|
|
2002
|
37 |
2 |
p. xi-
1 p.
|
artikel
|
| 4 |
Contents continued
|
|
|
2002
|
37 |
2 |
p. xii-
1 p.
|
artikel
|
| 5 |
Defected expression of E-cadherin in non-small cell lung cancer
|
Fei, Qingyan
|
|
2002
|
37 |
2 |
p. 147-152
6 p.
|
artikel
|
| 6 |
Expression of estrogen receptors α and β in human lung tissue and cell lines
|
Mollerup, Steen
|
|
2002
|
37 |
2 |
p. 153-159
7 p.
|
artikel
|
| 7 |
Gemcitabine and vascular toxicity
|
Muñoz, A
|
|
2002
|
37 |
2 |
p. 229-
1 p.
|
artikel
|
| 8 |
Immunologic parameters as significant prognostic factors in lung cancer
|
Nakamura, Haruhiko
|
|
2002
|
37 |
2 |
p. 161-169
9 p.
|
artikel
|
| 9 |
Incidental surgical findings of a phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with unresectable non-small cell lung cancer
|
Cesario, Alfredo
|
|
2002
|
37 |
2 |
p. 207-212
6 p.
|
artikel
|
| 10 |
Late events and clinical prognostic factors in stage I non small cell lung cancer
|
Pasini, Felice
|
|
2002
|
37 |
2 |
p. 171-177
7 p.
|
artikel
|
| 11 |
Older people with non small cell lung cancer in clinical stage IIIA and co-morbid conditions
|
Pergolizzi, Stefano
|
|
2002
|
37 |
2 |
p. 201-206
6 p.
|
artikel
|
| 12 |
Patient and GP led delays in the recognition of symptoms suggestive of lung cancer
|
Bowen, E.Frances
|
|
2002
|
37 |
2 |
p. 227-228
2 p.
|
artikel
|
| 13 |
Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer
|
Billingham, L.J
|
|
2002
|
37 |
2 |
p. 219-225
7 p.
|
artikel
|
| 14 |
Phase I study of weekly CPT-11 (irinotecan)/docetaxel in patients with advanced solid tumors
|
Font, A
|
|
2002
|
37 |
2 |
p. 213-218
6 p.
|
artikel
|
| 15 |
Pulmonary neuroendocrine tumors: Incidence and prognosis of histological subtypes. A population-based study in Denmark
|
Skuladottir, Halla
|
|
2002
|
37 |
2 |
p. 127-135
9 p.
|
artikel
|
| 16 |
Report on the second IASLC China workshop on lung cancer
|
Zejian, Li
|
|
2002
|
37 |
2 |
p. 233-
1 p.
|
artikel
|
| 17 |
Review of the book ‘Mesothelioma’
|
Baas, Paul
|
|
2002
|
37 |
2 |
p. 231-
1 p.
|
artikel
|
| 18 |
Role of granulocyte and granulocyte-macrophage colony-stimulating factors in the treatment of small-cell lung cancer: a systematic review of the literature with methodological assessment and meta-analysis
|
Berghmans, T
|
|
2002
|
37 |
2 |
p. 115-123
9 p.
|
artikel
|
| 19 |
The ‘reservoir’ of undetected bronchial carcinomas in the general population
|
Koyi, Hirsh
|
|
2002
|
37 |
2 |
p. 137-142
6 p.
|
artikel
|
| 20 |
The role of colony stimulating factors in small cell lung cancer
|
Trillet-Lenoir, V
|
|
2002
|
37 |
2 |
p. 125-126
2 p.
|
artikel
|
| 21 |
Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB–IV non-small cell lung carcinoma: a prospective randomized study
|
Gebbia, Vittorio
|
|
2002
|
37 |
2 |
p. 179-187
9 p.
|
artikel
|
Tijdschrift beschrijving